RichardsonP, RapporteurW, McKennaMD, Report of the WHO/ISFC task force on definition and classification of cardiomyopathies. Circulation1996;93:841–842.
2.
Gilbert-BarnessE.Cardiovascular disorders. In: Gilbert-BarnessE, ed. Potter's Pathology of the Fetus and Infant. St. Louis: Mosby1997;648–711.
3.
WoodsJR, PlessingerMA. Maternal, placental and fetal pathophysiology of cocaine exposure during pregnancy. Clin Obstet Gynecol1993;36:267–278.
4.
GriffinML, HernandezA, MartinTC, Cardiomyopathy. J Am Coll Cardiol1988;11:139–344.
5.
ArolaA, TuominenJ, RuuskanenO, JokinenE.Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics1998;101:369–376.
6.
InoT, BensonLN, FreedomRM, etal: Natural history and prognostic risk factors in endocardial fibroelastosis. Am J Cardiol1988;62:431–434.
7.
NeusteinHB, LuriePR, FugitaM.Endocardial fibroelastosis found on transvascular endomyocardial biopsy in children. Arch Pathol Lab Med1979;103:214–219.
8.
MuntoniF, CauM, GanauA, Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med1993;329:921–925.
9.
LeidenJM. The genetics of dilated cardiomyopathy— emerging clues to the puzzle. N Engl J Med1997;337:1080–1083.
10.
AbreoK, OberleyTD, GilbertEF, Clinicopathological conference: a 29-year-old man with recurrent episodes of fever, abdominal pain, and vomiting. Am J Med Genet1984;18:249–264.
11.
GilbertEF. The effects of metabolic diseases on the cardiovascular system. Am J Cardiovasc Pathol1987;1:189–213.
12.
FerransVJ, BoyceSW. Metabolic and familial diseases. In: SilverMD, ed. Cardiovascular Pathology, 2nd ed. New York: Churchill Livingstone, 1991;945–1004.
DiMauroS, HartwigGB, HaysAP, Debrancher deficiency: neuromuscular disorders in five adults. Ann Neurol1979;5:422–436.
28.
MosesSW, WandermannKL, MyrozA, Cardiac involvement in glycogen storage disease type III. Eur J Pediatr1989;148:764–766.
29.
ServideiS, RiepeRE, LangstonC, Severe cardiomyopathy in branching enzyme deficiency. J Pediatr1987;111:51–56.
30.
MirandaAF, NetteG, HartlageP, Phosphorylase isoenzymes in normal and myophosphorylase-deficient human heart. Neurology1979;29:1538–1541.
31.
HayflickS, RoweS, Kavanaugh-McHughA, Acute infantile cardiomyopathy as a presenting feature of mucopolysaccharidosis. J Pediatr1992;120:269–272.
32.
HaustMD, GordonBA, HongR, Clinicopathologic conference: an adolescent girl with severe mental impairment and mucopolysaccharidosis. Am J Med1985;22:1–27.
33.
HerdJK, SubramanianS, RobinsonH.Type III mucopolysaccharidosis: report of a case with severe mitral valve involvement. J Pediatr1973;82:101–104.
34.
BlankE, LinderD.I-cell disease (mucolipidosis II): a lysosomopathy Pediatrics1974;54:797–805.
35.
GilbertEF, DawsonG, ZuRheinGM, I-cell disease, mucolipidosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases. Z Kinderheilkd1973;114:259–292.
NagashimaK, SakakibaraK, EndoH, I-cell disease (mucolipidosis II). Pathological and biochemical studies of an autopsy case. Acta Pathol Jpn1977;27:251–264.
38.
PatriquinHB, KaplanP, KindHP, GiedionA.Neonatal mucolipidosis II (I-cell disease): clinical and radiologic features in three cases. AJR Am J Roentgenol1977;129:37–43.
39.
RobertsWC, FredricksonDS. Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis. Circulation1967;35:783–789.
ParkinsonJE, SunshineA.Angiokeratoma corporis diffusum universale (Fabry) presenting as suspected myocardial infarction and pulmonary infarcts. Am J Med1961;31:951–958.
42.
WiseD, WallaceHJ, JellinekEH. Angiokeratoma corporis diffusum. A clinical study of eight affected families. Q J Med1962;31:177–206.
43.
FritzP, SchneiderH, HeimburgP, WegnerG.Sekundare hypertrophe obstruktive Kardiomyopathic bei Morbus Fabry. Med Welt1978;29:1851–1854.
44.
LederAA, BosworthWC. Angiokeratoma corporis diffusum universale (Fabry's disease) with mitral stenosis. Am J Med1965;38:814–819.
45.
DubachUC, GloorF.Fabry-Krankheit (Angiokeratoma corporis diffusum universale). Phosphatidspei-cherkrankheit bei zwei Familien. Dtsch Med Wochenschr1966;91:241–245.
46.
BeckerAE, SchorlR, BalkAG, Cardiac manifestations of Fabry's disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction. Am J Cardiol1975;36:829–835.
47.
DesnickRJ, BliedenLC, SharpHL, Cardiac valvular anomalies in Fabry disease. Clinical, morphologic and biochemical studies. Circulation1976;54:818–825.
48.
DuncanC, McLeonGM. Angiokeratoma corporis diffusum universale (Fabry's disease): a case with gross myocardial involvement. Australas Ann Med1970;19:58–61.
49.
FerransVJ, HibbsRG, BurdaCD. The heart in Fabry's disease. A histochemical and electron microscopic study. Am J Cardiol1969;24:95–110.
50.
RothJ, RothH.Elektronenmikroskopische Befunde an inneren Organen bei Morbus Fabry. Virchows Arch A Pathol Pathol Anat1978;378:75–90.
51.
GonatasNK, GonatasJ.Ultrastructural and biochemical observations on a case of systemic late infantile lipidosis relationship to Tay-Sachs disease and gargoylism. J Neuropathol Exp Neurol1965;24:318–340.
52.
HadleyRN, HagstromJWC. Cardiac lesions in a patient with familial neurovisceral lipidosis (generalized gangliosidosis). Am J Clin Pathol1971;55:237–240.
53.
GilbertEF, VarakisJ, OpitzJM, Generalized gangliosidosis type II (juvenile GM gangliosidosis). A pathological, histochemical and ultrastructural study. Z Kinderheilkd1975;120:151–180.
54.
Rodriquez-TorresR, SchneckL, KleinbergW.Electrocardiographic and biochemical abnormalities in Tay-Sachs disease. Bull NY Acad Med1971;47:717–730.
55.
BarnessLA, HenryK, KlingP, LaxovaR, KabackM, Gilbert-BarnessE.Clinico-pathological report: a 7-year-old white-male boy with progressive neurological deterioration. Am J Med Genet1991;40:271–279.
56.
BliedenLC, DesnickRJ, CarterJB, Cardiac involvement in Sandhoff's disease. Inborn error of glycosphingolipid metabolism. Am J Cardiol1974;34:83–88.
57.
DolmanCL, ChangE, DukeRJ. Pathologic findings in Sandhoff disease. Arch Pathol1973;96:272–275.
58.
KrivitW, DesnickRJ, LeeJ, Generalized accumulation of neutral glycosphingolipids with GM2 gangliosidosis accumulation in the brain. Sandhoff's disease (variant of Tay-Sachs disease). Am J Med1972;52:763–770.
59.
ZemanW, DonahueS, DykenP, The neuronal ceroid lipofuscinosis (Batten-Vogt syndrome. In: VinkenPJ, BruynGW, eds. Handbook of Clinical Neurology, Vol. 10. Amsterdam: North Holland, 1970;588.
60.
MileyCEIII, GilbertEF, FranceTD, Clinical and extraneural histologic diagnosis of neuronal ceroid-lipofuscinosis. Neurology1978;28:1008–1012.
61.
MirandaAF, DiMauroS, EastwoodAB, Lipid storage, ichthyosis and steatorrhea. Muscle Nerve1979;2:1–13.
62.
IbayashiH, IdeguchiH, HaradaN, Systemic triglyceride storage disease with normal carnitine: a putative defect in long-chain fatty acid metabolism. J Neurol Sci1988;85:149–159.
63.
DiDonatoS, GaravagliaB, StrisciuglioP, Multisystemic triglyceride storage disease is due to a specific defect in the degradation of endocellularly synthesized triglycerides. Neurology1988;38:1107–1110.
64.
QualmanSJ, MoserHW, ValleD, Farber disease: pathologic diagnosis in sibs with phenotypic variability. In: Topics in Pediatric Genetic Pathology. Enid Gilbert-Barness Festschrift. Am J Med Genet Suppl1987;3:233–241.
65.
TrippME, KatcherML, GilbertEF, Systemic carnitine deficiency presenting as familial endocardial fibroelastosis. N Engl J Med1981;305:385–389.
66.
WaberLJ. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediatr1982;101:700–705.
67.
BremerJ.Carnitine-metabolism and functions. Physiol Rev1983;63:1420–1480.
68.
KarpatiG, CarpenterS, EngelAG, The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemical and pathophysiologic features. Neurology1975; 25:16–24.
69.
EngelAG, ReboucheCJ. Pathogenetic mechanisms in human carnitine deficiency syndromes. In: SchotlandDL, ed. Disorders of the Motor Unit. New York: John Wiley & Sons, 1982;643.
HugG, BoveKE, SoukupS.Lethal neonatal multiorgan deficiency of CPT-II. N Engl J Med1991;325:1862–1864.
72.
StraussAW, PowellCK, HaleDE, Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci USA1995;92:10496–10500.
73.
SimsHF, BrackettJC, PowellCK, The molecular basis of pediatric long chain 3-hydroxy-acyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA1995;92:841–845.
74.
WallaceD.Diseases of mitochondrial DNA. Annu Rev Biochem1992;61:1175–1212.
75.
JohnsDR. Mitochondrial DNA and disease. N Engl J Med1995;333:638–644.
76.
PageE, PolimeniPI, ZakR, Myofibrillar mass in rat and rabbit heart muscle. Circ Res1972;30:430–439.
77.
PetersTJ, WellsG, OakleyCM, Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. Br Heart J1977;39:1333–1339.
78.
RomanskySG: Neuromuscular diseases. In: Gilbert-BarnessE, ed. Potter's Pathology of the Fetus and Infant. St. Louis: Mosby Publishing, 1997;1378–1422.
79.
RustinP, LebidoisJ, ChretienD, Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies. J Pediatr1994;124:224–228.
80.
CarafoliE.Mitochondria and disease. Mol Aspects Med1980;3:395–429.
81.
EggerJ, LakeBD, WilsonJ.Mitochondrial cytopathy: a multisystem disorder with ragged red fibers on muscle biopsy. Arch Dis Child1981;56:741–752.
82.
NeusteinHB, LuriePR, DahmsB, An X-linked recessive cardiomyopathy with abnormal mitochondria. Pediatrics1979;64:24–29.
83.
KelleyRI, CheathamJP, ClarkBJ, X-linked dilated cardiomyopathy with neutropenia and 3-methylglutoconic aciduria. J Pediatr1991;119:738–747.
84.
AdesLC, GedeonAK, WilsonMJ, Barth syndrome: clinical features and confirmation of gene localization to distal Xq28. Am J Med Genet1993;45:327–334.
85.
EggerJ, WilsonJ.Mitochondria inheritance in a mitochondrially mediated disease. N Engl J Med1983;303:142–146.
86.
VogelU, KendziorraH, Mackensen-HaenS, Mitochondrial cardiomyopathy. Pediatr Pathol Lab Med Abst1997;17:710.
87.
Gilbert-BarnessE.Metabolic cardiomyopathy in childhood. In: PomeranceHH, BercuBB, eds. Topics in Pediatrics Lewis Barness Festschrift. New York: Springer-Verlag, 1990;122–153.
88.
PapadimitriouA, NeusteinHB, DiMauroS, Histiocytoid cardiomyopathy of infancy: deficiency of reducible cytochrome b in heart mitochondria. Pediatr Res1985;18:1023–1028.
89.
DimauroS.Mitochondrial encephalomyopathies. In: RosenbergRH, PrusinerSB, DiMauroS, , eds. The Molecular and Genetic Basis of Neurological Disease. Boston: Butterworth-Heinemann, 1993;665.
90.
DiMauroS, LombesA, NakaseH, Cytochrome c oxidase deficiency. Pediatr Res1990;28:536–541.
91.
RimoldiM, BottacchiE, RossiL.Cytochrome c oxidase deficiency in muscle of a floppy infant without mitochondrial myopathy. J Neurol1982;227:201–207.
92.
ZevianiM, Van DykeDH, ServideiS, Myopathy and fatal cardiomyopathy due to cytochrome c oxidase deficiency. Arch Neurol1986;43:1198–1202.
93.
KennawayNG, Carrero-ValenzuelaRD, EwartG, Isoforms of mammalian cytochrome c oxidase: correlation with human cytochrome c oxidase deficiency. Pediatr Res1990;28:529–535.
94.
SchwartzkopffB, ZierzS, FrenzalH, Ultrastructural abnormalities of mitochondria and deficiency of myocardial cytochrome c oxidase in a patient with ventricular tachycardia. Virchows A Pathol Anat Histopathol1991; 419:63–68.
95.
HolmeE, GreterJ, JacobsonCE, Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria. Pediatr Res1992;32:731–735.
96.
TulniusMH, ErikssonBO, HjelmarssonO, Mitochondrial myopathy and cardiomyopathy in siblings. Pediatr Neurol1989;5:182–188.
97.
OldorfsA, SommerlandH, HolmesE, Cytochrome c oxidase deficiency in infancy. Acta Neuropathol1989;77:267–275.
98.
ZhengX, ShoffnerJM, LottMT, Evidence in a lethal infantile mitochondrial disease for a nuclear mutation affecting respiratory complexes I and IV. Neurology1989; 39:1203–1209.
99.
KorenkeGC, BentlageHACM, RuitenbeckW, Isolated and combined deficiencies of NADH dehydrogenase (complex I) in muscle tissue of children with mitochondrial myopathies. Eur J Pediatr1990;150:104–108.
100.
SengersRCA, TrijbelsJMF, BakkerenJAJ, Deficiency of cytochrome b and aa3 in muscle from a floppy infant with cytochrome c oxidase deficiency. Eur J Pediatr1984;141:178–180.
101.
Müller-HöckerJ, IbelH, PaetzkeI, Fetal infantile mitochondrial cardiomyopathy and myopathy with heterogenous tissue expression of combined respiratory chain defects. Virchows Arch A Pathol Anat Histopathol1991; 419:355–362.
102.
ServideiS, BertiniE, ManfrediG, Familial infantile myopathy and cardiomyopathy with deficiency of cytochrome c oxidase (COX) and mitochondrial ATP-synthase (ATP-S) [abstract]. Ann Neurol1993;34:463.
103.
SengersRCA, Ter HaarBGA, TrijbelsJMF, Congenital cataract and mitochondrial myopathy of skeletal and heart muscle associated with lactic acidosis after exercise. J Pediatr1975;86:873–880.
104.
SmeitinkJAM, SengersRCA, TrijbelsJMF, Fatal neonatal cardiomyopathy associated with cataract and mitochondrial myopathy. Eur J Pediatr1989;148:656–659.
105.
ServideiS, Dionisi-Vici, BertiniE, “Sengers disease” with deficiency of respiratory complexes I and IV [abstract]. Ital J Neurol Sci1990;11:194.
106.
FinchSC, FinchCA. Idiopathic hemochromatosis, an iron storage disease. Medicine1955;34:381.
107.
BujaLM, RobertsWC. Iron in the heart. Etiology and clinical significance. Am J Med1971;52:209–221.
108.
LewisHP. Cardiac involvement in hemochromatosis. Am J Med Sci1954;227:544.
109.
KniselyAS, GradyRW, KramerEE, Cytoferrin, maternofetal iron transport, and neonatal hemochromatosis. Am J Clin Pathol1989;92:755–759.
110.
Gilbert-BarnessE, BarnessLA. Disorders of metal metabolism. In: Metabolic Disorders. Natick, MA: Eaton, 1999 (in press).
111.
BottigerLE, MollerbergH.Increased copper content of hypertrophic myocardium. Acta Med Scand1959;165:413.
DubinIN. Chronic idiopathic jaundice. A review of fifty cases. Am J Med1958;24:268.
118.
DubinIN, JohnsonFB. Chronic idiopathic jaundice with unidentified pigment in the liver cells. A new clinicopathological entity with a report of twelve cases. Medicine1954;33:155.
119.
SprinzH, NelsonRS. Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: report of four cases. Ann Intern Med1954;14: 952.
120.
WegmanR, RangierM, EteveJ, Melanose hepatosplenique avec ictere chronique à bilirubine directe: maladie de Dubin-Johnson? Histochimique et spectrographique du pigment abnormal. Semin Hop Paris1960;36:1761.
121.
ButtHR, AndersonVE, FaulkWT, Studies of chronic idiopathic jaundice (Dubin-Johnson syndrome). II. Evaluation of a large family with the trait. Gastroenterology1966;51:619–630.
122.
GoldsteinJI, HobbsH, BrownMS. Familial hypercholesterolemia. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York: McGraw Hill, 1995;1981–2030.
123.
BujaLM, KovanenPT, BilheimerDW. Cellular pathology of homozygous familial hypercholesterolemia. Am J Pathol1979;97:327–357.
124.
WatkinsH, McKennaWJ, ThierfelderL, Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med1995; 332:1058–1064.
125.
WatkinsH, RosenzweigA, HwangD-S, Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med1992;326:1108–1114.
126.
SchwartzK, CarrierL, GuicheneyP, KomajdaM.Molecular basis of familial cardiomyopathies. Circulation1995; 91:532–540.
127.
MarianAL, RobertsR.Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation1995;92:1336–1347.
128.
LeidenJM. The genetics of dilated cardiomyopathy— emerging clues to the puzzle. N Engl J Med1997;337:1080–1083.
129.
ThierfelderL, WatkinsH, MacRaeC, α-Tropomyo-sin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell1994;77:701–712.
130.
WatkinsH, AnnaR, CovielloDA, A de novo mutation in α-tropomyosin that causes hypertrophic cardiomyopathy. Circulation1995;91:2302–2305.
131.
WatkinsH, ConnorD, ThierfelderL, Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet1995;11:434–435.
132.
BonneG, CarrierL, BercoviciJ, Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet1995;11:438–440.
133.
PoetterK, JiangH, HassanzadehS, Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet1996;13:63–69.
134.
NimuraH, BachinskiLL, SangwatanarojS, Mutations in the gene for cardiac myosin binding protein C and late-onset familial hypertrophic cardiomyopathy. New Engl J Med1998;338:1248–1257.
135.
SuttonMSJ, EpsteinJA. Hypertrophic cardiomyopathy— beyond the sacromere. New Engl J Med1998;338:1303–1304.
136.
LoganF, KuhnH, GietzenF, Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J1983;4:145–153.
137.
BraunwaldE, LambrewCT, RockoffSD, Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation1964;30: Suppl IV:3.
138.
SavageDD, SeidesSF, ClarkCE, Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation1978; 58:402–408.
139.
YamaguchiH, IshimuraT, NishiyamaS, Hypertro-phic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol1979;44:401–412.
140.
AlfonsoF, NihoyannopoulosP, StewartJ, DickieS, Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol1990;15:965–971.
141.
RasmussenH, TenenhouseHS. Mendelian hypophosphatemias. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995;3717.
142.
AbbasiAS, MacAlpinRN, EberLM, PearceML. Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation1972;46:897–904.
143.
ShahPM, GramiakR, AdelmanAG, WigleED. Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis. Circulation1971; 44:891–898.
144.
TajikAJ, GiulianiER. Echocardiographic observations in idiopathic hypertrophic subaortic stenosis. Mayo Clin Proc1974;49:89–97.
145.
HenryWL, ClarkCE, EpsteinSE. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation1973;47:225–233.
146.
MaronBJ, GottdienerJS, EpsteinSE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol1981;48:418–428.
147.
MaronBJ, GottdienerJS, BonowRO, EpsteinSE. Hyper-trophic cardiomyopathy with unusual locations of left ventricular hypertrophy undetectable by M-mode echocardiography. Identification by wide-angle two-dimensional echocardiography. Circulation1981;63:409–418.
148.
ShapiroLM, McKennaWJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A two-dimensional echocardiographic study. J Am Coll Cardiol1983;2:437–444.
149.
CrileyJM, LewisKB, WhiteRI, RossRS. Pressure gradients without obstruction. A new concept of “hypertrophic subaortic stenosis.” Circulation1965;32:881.
150.
DaviesMJ, McKennaWJ. Hypertrophic cardiomyopathy— pathology and pathogenesis. Histopathology1995;26:493–500.
151.
PomeranceA, DaviesMJ. Pathological features of hyper-trophic obstructive cardiomyopathy (HOCM) in the elderly. Br Heart J1975;37:305–312.
152.
McKennaWJ, KleinebenneA, NihoyannopoulosP, FoaleR.Echocardiographic measurement of right ventricular wall thickness in hypertrophic cardiomyopathy: relation to clinical and prognostic features. J Am Coll Cardiol1988;11:351–358.
153.
DaviesMJ. The current status of myocardial disarray in hypertrophic cardiomyopathy. Br Heart J1984;51:361–368.
154.
MaronBJ, AnanTJ, RobertsWC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation1981;63:882–894.
155.
FerransVJ, MorrowAG, RobertsWC. Myocardial ultra-structure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation1972;45:769–792.
156.
BeckerAE, CarusoG.Myocardial disarray. A critical review. Br Heart J1982;47:527–538.
157.
BulkleyBH, WeisfeldtML, HutchinsGM. Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts. Circulation1977;56:292–298.
158.
BonowRO, RosingDR, BacharachSL, Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation1981;64:787–796.
159.
LorellBH. Use of calcium channel blockers in hypertrophic cardiomyopathy. Am J Med1985;78:43–54.
160.
HanrathP, MatheyDG, SiegertR, BleifeldW.Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study. Am J Cardiol1980;45:15–23.
161.
BetocchiS, BonowRO, BacharachSL, Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography. J Am Coll Cardiol1986;7:74–81.
162.
ThompsonDS, NaqviN, JuulSM, Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J1980;44:488–498.
163.
HarrisonDC, BraunwaldE, GlickG, Effects of beta adrenergic blockade on the circulation, with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation1964;29:84.
164.
CohenLS, BraunwaldE.Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade. Circulation1967;35:847–851.
165.
ZipesDP. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest? Circulation1995;91:2115–2117.
166.
CeremuzynskiL, KleczarE, Krzeminska-PakulaM, Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol1992;20:1056–1062.
167.
The CASCADE Investigators.Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol1993;72:280–287.
168.
McKennaWJ, GoodwinJF. The natural history of hyper-trophic cardiomyopathy. Curr Prob Cardiol1981;6:1–26.
169.
KirklinJW, Barratt-BoyesBG. Cardiac Surgery. New York: John Wiley & Sons, 1986.
170.
SeilerC, HessOM, SchoenbeckM, Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol1991;17:634–642.
171.
MaronBJ, MerrillWH, FreierPA, KentKM. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation1978;57:1205–1213.
McIntoshCL, GreenbergGJ, MaronBJ, Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Ann Thorac Surg1989;47:236–246.
174.
ten BergJM, SuttorpMJ, KnapenPJ, Hypertrophic obstructive cardiomyopathy: initial results and long-term follow-up after Morrow septal myectomy. Circulation1994;90:1781–1785.
175.
RobbinsRC, StinsonEB. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg1996;111:586–594.
176.
McCullyRB, NishimuraRA, TajikAJ, Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation1996;94:467–476.
177.
CooperMM, McIntoshCL, TuckerE, ClarkRE. Operation for hypertrophic subaortic stenosis in the aged. Ann Thorac Surg1987;44:370–378.
178.
SiegmanIL, MaronBJ, PermutLC, Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary artery disease. J Am Coll Cardiol1989;13:1527–1533.
179.
MarwickTH, StewartWJ, LeverHM, Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy. J Am Coll Cardiol1992;20:1066–1072.
180.
GriggLE, WigleED, WilliamsWD, Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance of intraoperative decision making. J Am Coll Cardiol1992;20:42–52.
181.
SpiritoP, SeidmanCE, McKennaWJ, MaronBJ. The management of hypertrophic cardiomyopathy. N Engl J Med1997;336:775–785.
182.
SadoulN, PrasadK, ElliottPM, Prospective diagnostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation1996;96:2987–2991.
183.
JosephS, BalconR, McDonaldL.Syncope in hypertrophic obstructive cardiomyopathy due to asystole. Br Heart J1972;34:974–976.
184.
ChmielewzkiCA, RileyRS, MahendranA, MostAS. Complete heart block as a cause of syncope in asymmetric septal hypertrophy. Am Heart J1977;93:91–93.
185.
GilliganDM, NihoyannopoulosP, ChanWL, OakleyCM. Investigation of a hemodynamic basis for syncope in hypertrophic cardiomyopathy: use of a head-up tilt test. Circulation1992;85:2140–2148.
186.
McKennaW, HarrisL, DeanfieldJ.Syncope in hypertrophic cardiomyopathy. Br Heart J1982;47:177–179.
187.
NienaberCA, HillerS, SpielmannRP, Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol1990;15:948–955.
188.
DilsizianV, BonowRO, EpsteinSE, FananapazirL.Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol1993;22:796–804.
189.
SeggewissH, GleichmannU, FaberL.The management of hypertrophic cardiomyopathy. N Engl J Med1997;337:349–350.
190.
FrankelKA, RosserRJ. The pathology of the heart in progressive muscular dystrophy. Hum Pathol1976;7:375–386.
191.
MatsudaM, AkatsukaN, YamaguchiT, Systolic time intervals in patients with progressive muscular dystrophy of the Duchenne type. Jpn Heart J1977;18:638–651.
192.
PriorTW. Genetic analyses of the Duchenne muscular dystrophy gene. Arch Pathol Lab Med1991;115:984–990.
193.
RublerS, PerloffJK, RobertsWC. Duchenne's muscular dystrophy. Am Heart J1977;94:776–784.
194.
StorsteinO.The heart in progressive muscular dystrophy. Exp Med Surg1964;22:13.
195.
JamesTN. Observations on the cardiovascular involvement, including the cardiac conduction system, in progressive muscular dystrophy. Am Heart J1962;63:48.
196.
PerloffJK, RobertsWC, DeLeonACJr., O'DohertyD.The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. Am J Med1967;42:179–188.
197.
SannyalSK, JohnsonWW, ThaparMK, PitnerSE. An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy. Circulation1978;57:1122–1129.
198.
SanynalSK, JohnsonWW, DischeMR, Dystrophic degeneration of papillary muscle and ventricular myocardium. A basis for mitral valve prolapse in Duchenne's muscular dystrophy. Circulation1980;62:430–438.
199.
BiddisonJH, DemboDH, SpaltH, Familial occurrence of mitral valve prolapse in X-linked muscular dystrophy. Circulation1979;59:1299–1304.
200.
DonofrioPD, ChallaVR, HackshawBT, Cardiac transplantation in a patient with muscular dystrophy and cardiomyopathy. Arch Neurol1989;46:705–707.
201.
PrystowskyEN, PritchettELC, RosesAD, The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation1979;60:1360–1364.
202.
RosesAD. Myotonic dystrophy. In: RosenbergRN, PrusinerSB, DiMauroS, eds. The Molecular and Genetic Bases of Neurological Diseases. Boston: Butterworth-Heinemann, 1993.
203.
SarnatHB, O'ConnorT, ByrnePA. Clinical effects of myotonic dystrophy on pregnancy and the neonate. Arch Neurol1976;33:459–465.
204.
ShelbourneP, DaviesJ, BuxtonJ, Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N Engl J Med1993;328:471–475.
205.
KuhnE, FiehnW, SchroderJM, Early myocardial disease and cramping myalgia in Becker-type muscular dystrophy. A kindred. Neurology1979;29:1144–1149.
206.
MeierC, GertschM, ZimmermanA, Nemaline myopathy presenting as cardiomyopathy. N Engl J Med1983;308:1536–1537.
207.
PearsonCM. Myotubular myopathy. In: BergsdmaD, ed. Birth Defects Compendium. New York: National Foundation, 1979.
208.
PerloffJK. The myocardial disease of heredofamilial neuromyopathies. In: FowlerNO, ed. Myocardial Disease. New York: Grune and Stratton, 1973;319.
209.
HardingAE, HewerRL. The heart in Friedrich's ataxia. Q J Med1983;52:489–502.
210.
IvemarkB, ThorenC.The pathology of the heart in Friedreich's ataxia. Changes in coronary arteries and myocardium. Acta Med Scand1964;175:227.
211.
SchileroAJ, AntziaE, DunnJ.Friedreich's ataxia and its cardiac manifestations. Am Heart J1952;44:805.
212.
BarrillonA, BensaidJ, CoiraultR, Myocardiopathie obstructive et maladie de Friedreich. Arch Mal Coeur Vaiss1973;66:1525–1535.
213.
GachJV, AndriangeM, FranckG.Hypertrophic obstructive cardiomyopathy and Friedreich's ataxia. Report of a case and review of literature. Am J Cardiol1971;117:436.
214.
PernotC.La Myocardiopathie de la maladie de Friedreich. A propos d'une serie de 17 observations. Arch Fr Pediatr1979;36:11–18.
215.
SmithER, SangalangVE, HoffernanLP, Hypertro-phic cardiomyopathy: the heart disease of Friedreich's ataxia. Am Heart J1977;94:428–434.
216.
DubowitzV.Muscle disorders in childhood. Major Prob Clin Pediatr1978;16:1–282.
217.
HuckellVR, StaniloffHM, BrittBA, Cardiac manifestations of malignant hyperthermia susceptibility. Circulation1978;58:916–925.
218.
KramerLD, ColeJP, MessengerJC, EllistadMH. Cardiac dysfunction in a patient with familial hypokalemic periodic paralysis. Chest1979;75:189–192.
219.
KassS, MacRaeC, GraberHL, A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1.1q1. Nat Genet1994;7:546–551.
220.
OlsonTM, KeatingMT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest1996;97:528–532.
221.
KrajinovicM, PinamontiB, SinagraG, Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet1995;57:846–852.
222.
BowlesKR, GajarskiR, PorterP, Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest1996;98:1355–1360.
223.
StraussAW, JohnsonMC. The genetic basis of pediatric cardiovascular disease. Semin Perinatol1996;20:564–576.
224.
AbcheeA, MarianAJ. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hyper-trophic expressivity in patients with hypertrophic cardiomyopathy. J Invest Med1997;45:191–196.
225.
McAllisterHAJr.Collagen vascular diseases and the cardiovascular system. In: SilverMD, ed. Cardiovascular Pathology. New York: Churchill Livingstone, 1983.
226.
HoustonHE. Abdominal aortic aneurysm in Marfan's syndrome. J Ky Med Assoc1978;76:492–493.
227.
ThileniusOG, BharatiS, ArcillaRA, Cardiac pathology of Marfan's syndrome: can dissection and rupture of aortic aneurysms be prevented? Cardiology1980;65:193–204.
228.
McKusickVA. The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue. Circulation1955;11:321.
229.
JulienJ, De BoucaudD.Aneurysme dans le systeme de la veine de Galien et syndrome de Marfan. Bordeaux Med1971;4:3245–3252.
230.
CrisfieldRJ. Spontaneous aneurysm of the ductus arteriosus in a patient with Marfan's syndrome. J Thorac Cardiovasc Surg1971;62:243–247.
231.
FournierC.Les Lesions cardio-vasculaires du syndrome de Marfan. Coeur Med Intern1977;16:331–336.
232.
EldridgeR.Coarctation in the Marfan syndrome. Arch Intern Med1964;113:342.
233.
MarvelRJ, GenovesPD. Cardiovascular disease in Marfan's syndrome. Am Heart J1951;42:814.
234.
SarukM, EisensteinR.Aortic lesion in Marfan syndrome. The ultrastructure of cystic medial degeneration. Arch Pathol Lab Med1977;101:74–77.
235.
DietzHC, CuttingGR, PyeritzRE, Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature1991;352:337–339.
236.
KainulainenK, KarttunenL, PuhakkaL, Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet1994;6:64–69.
237.
DietzHC, PyeritzRE. Mutations in the human gene for fibrillin-1 (FBNI) in the Marfan syndrome and related disorders. Hum Mol Genet1995;4:1799–1809.
238.
PyeritzRE, McKusickVA. The Marfan syndrome: diagnosis and management. N Engl J Med1979;300:772–777.
239.
DietzHC. Molecular biology of Marfan's syndrome. J Vasc Surg1992;15:927–928.
240.
LeeB, GodfreyM.Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature1991;352:330–334.
241.
McKusickVA. The defect in Marfan syndrome. Nature1991;352:279–281.
242.
OgilvieDJ, WordsworthBP, PriestleyLM. Segregation of all four major fibrillar collagen genes in the Marfan syndrome. Am J Hum Genet1987;41:1071–1082.
243.
BeightonP.Lethal complications of the Ehlers-Danlos syndrome. BMJ1968;3:656–659.
244.
RotbergT, SanagustinMT, SalinasL, Sindrome de Ehlers-Danlos associado a communicacion interauricular, bloqueo A-V completo, aneurisma de aorta y crecimento del ventriculo izquierdo (miocardiopatia). Arch Inst Cardiol Mex1977;47:562–571.
245.
BurnettHF, BledsoeJH, CharF, Abdominal aortic aneurysmectomy in a 17-year-old patient with Ehlers-Danlos syndrome: case report and review of the literature. Surgery1973;74:617–620.
246.
ScullyRE, GaldabiniJJ, McNeelyBU. Case records of the Massachusetts General Hospital, case 3-1979. N Engl J Med1979;300:129–136.
247.
Duplicate reference deleted in proof.
248.
BarabasAP. Vascular complications in the Ehlers-Danlos syndrome. With special reference to the “arterial type” or “Sack's syndrome.” J Cardiovasc Surg1972;13:160–167.
249.
SchoolmanA, KepesJJ. Bilateral spontaneous carotid cavernous fistulae in Ehlers-Danlos syndrome. Case report. J Neurosurg1967;26:82–86.
250.
UmlasJ.Spontaneous rupture of the subclavian artery in the Ehlers-Danlos syndrome. Hum Pathol1972;3:121–126.
251.
WenstrupRJ, WellingMC, StarmanBJ, ByersPH. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. Am J Hum Genet1990;46:975–982.
SillenceDO, SennA, DanksDM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet1979;16:101–116.
254.
WheelerVR, CooleyNR, BlackburnWR. Cardiovascular pathology in osteogenesis imperfecta type IIA with a review of the literature. Pediatr Pathol1988;8:55–64.
255.
GoodmanRM, SmithEW, PatonD, Pseudoxanthoma elasticum: a clinical and histopathological study. Medicine1963;42:297.
SchachnerL, YoungD.Pseudoxanthoma elasticum with severe cardiovascular disease in a child. Am J Dis Child1974;127:571–575.
258.
HaustMD. Maternal diabetes mellitus—effects on the fetus and placenta. In: NaeyeRI, KissaneJM, KaufmanN, eds. Perinatal Pathology. Baltimore: Williams and Wilkins, 1981;201–285.
ShehataBM, PattersonK, ThomasJE, Histiocytoid cardiomyopathy: three new cases and a review of the literature. Pediatr Dev Pathol1998;1:56–69.
273.
BirdLM, KrousHE, ElchenfieldLF. Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy. Am J Med Genet1994;53:141–148.
274.
McGregorCG, GibsonA, CavesP.Infantile cardiomyopathy with histiocytoid change in cardiac muscle cells: successful surgical intervention and prolonged survival. Am J Cardiol1984;53:982–983.
275.
HeifetzSA, FaughtPR, BaumanM.Pathological case of the month: histiocytoid (oncocytic) cardiomyopathy. Arch Pediatr Adolesc Med1995;149:464–465.
276.
FerransVJ, McAllisterHA, HaeseWH. Infantile cardiomyopathy with histiocytoid change in cardiac muscle cells. Report of six patients. Circulation1976;53:708–719.
277.
SaffitzJE, FerransVJ, RodriguezER, Histiocytoid cardiomyopathy: a cause of sudden death in apparently healthy infants. Am J Cardiol1983;52:215–217.
278.
ZimmermannA, DiemP, CottierH.Congenital “histiocytoid” cardiomyopathy: evidence suggesting a developmental disorder of the Purkinje cell system of the heart. Virchows Arch Pathol Anat Histopathol1982;396:187–195.
279.
FerransVJ. Pathologic anatomy of the dilated cardiomyopathies. Am J Cardiol1989;64:9C–11C.
280.
KaufmanSL, ChandraN, PeresNS, Idiopathic infantile cardiomyopathy with involvement of the conduction system. Am J Cardiol1972;30:648–652.
281.
Van HareGF. Radiofrequency ablation of cardiac arrhythmias in pediatric patients. Adv Pediatr1994;41:83–110.
MiloS, HoSY, WilkinsonJL, Surgical anatomy and atrioventricular conduction tissues of hearts with isolated ventricular septal defects. J Thorac Cardiovasc Surg1980;79:244–255.
284.
MichaelssonM, EngleMA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin1974;4:85–106.
285.
GuntherothWG, MotolskyAG. Inherited disorders of cardiac rhythm and conduction. Prog Med Genet1983;5:581–402.
286.
AbmanSH, WaradyBA, LumGM, Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr1984;104:928–931.
287.
McCueCM, MantakaME, TingelstadJB, Congenital heart block in newborns of mothers with connective tissue disease. Circulation1977;56:82–90.
288.
LitseySE, NoonanJA, O'ConnorWN, Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med1985;312:98–100.
289.
KulloLJ, EdwardsWD, SewardJB. Right ventricular dysplasia: the Mayo Clinic experience. Mayo Clin Proc1995;70:541–548.
290.
MarcusFL, FontaineGH, GuiraudonG, Right ventricular dysplasia: a report of 24 cases. Circulation1982;65:384–398.
291.
MarcusFL, FontaineG.Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review. Pacing Clin Electrophysiol1995;18:1298–1314.
292.
NavaA, ThieneG, CancianiB, Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol1988;12:1222–1228.
293.
DunganWT, GarsonAJr, GilletteDC. Arrhythmogenic right ventricular dysplasia: a cause of ventricular tachycardiain children with apparently normal hearts. Am Heart J1981;102:745–750.
294.
SabelKG, Blomstrom-LundquistC, OlssonSB. Arrhythmogenic right ventricular dysplasia in mother and sister: is it related to myocarditis? Pediatr Cardiol1990;11:113–116.
295.
ManyariDE, KleinGJ, GulamhuseinS, Arrhythmogenic right ventricular dysplasia: a generalized cardiomyopathy? Circulation1983;68:251–257.
296.
KirschLR, WeinstockDJ, MagidMS. Treatment of presumed arrhythmogenic right ventricular dysplasia in an adolescent. Chest1993;104:298–300.
297.
HochDH, RosenfieldLE. Tachycardias of right ventricular origin. Cardiol Clin1992;10:151–164.
298.
DalalP, FujisicK, HupartP, SchwietzerP.Arrhythmogenic right ventricular dysplasia: a review. Cardiology1994;85:361–369.
299.
ThieneG, NavaA, CorradoD, Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med1988;318:129–133.
300.
MisakiT, WatanabeG, IwaT, Surgical treatment of arrhythmogenic, right ventricular dysplasia: long-term outcome. Ann Thorac Surg1994;58:1380–1385.
301.
RampazzoA, NavaA, DanieliGA, The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet1994;3:959–962.
302.
DuŝekJ, OŝtádalB, DuŝkovaM.Postnatal persistence of spongy myocardium with embryonic blood supply. Arch Pathol1975;99:312–317.
303.
FreedomRM. Persistence of spongy myocardium—a form of congenital cardiomyopathy? In: FreedomRM, CulhamJAG, MoesCAF, eds. Angiocardiography of Congenital Heart Disease. New York: MacMillan, 1984;360–362.
304.
MichelRS, CarpenterMA, LovellMA. Pathological case of the month: noncompaction of the left ventricular myocardium. Arch Pediatr Adolesc Med1998;152:709–710.
305.
KeatingM, AtkinsonD, DunnC, Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey RAS-1 gene. Science1991;252:704–706.
306.
NeyroudN, TessonF, DenjoyI, A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet1997;15:186–189.
307.
TowbinJA, LiH, TaggartTR, Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: analysis of 23 families. Circulation1994;90:2635–2644.
308.
MossAJ, ZarebaW, BenhorinJ, ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation1995;92:2929–2934.
309.
ZorebaW, MossAJ, SchwartzPJ, Influence of the genotype in the clinical course of the long-QT syndrome. N Engl J Med1998;339:960–965.
310.
RussellMW. The molecular genetics of the long QT syndromes. Curr Opin Cardiol1996;11:45–51.
311.
TowbinJA, FriedmanRA. Prolongation of the QT interval and the sudden infant death syndrome [editorial]. New Engl J Med1998;338:1760–1761.
312.
SchwartzPJ, Stromba-BadialeM, SegantiniA, Prolongation of the QT interval and the sudden infant death syndrome. New Engl J Med1998;338:1709–1714.
313.
BaimD, RothmanM, HarrisonD.Improved catheter for regional sinus flow and metabolic studies. Am J Cardiol1980;45:997–1000.
314.
BaimD, RothmanM, HarrisonD.Simultaneous measurement of coronary venous blood flow and oxygen saturation during transient alterations in myocardial oxygen supply and demand. Am J Cardiol1982;49:743–752.
315.
KoberG, KunkelB, BeckerHJ, Technical aspects, experiences and complications of right and left ventricular endomyocardial biopsy. In: KaltenbachM, LoganF, OlsenEGT, eds. Cardiomyopathy and Myocardial Biopsy. New York: Springer-Verlag, 1978.
316.
DalyK.Significant incidence of mural thrombi in acute myocarditis—indication for early anticoagulation. J Am Coll Cardiol1983;1:584.